GB201308217D0 - Compounds and their use in therapy - Google Patents

Compounds and their use in therapy

Info

Publication number
GB201308217D0
GB201308217D0 GBGB1308217.7A GB201308217A GB201308217D0 GB 201308217 D0 GB201308217 D0 GB 201308217D0 GB 201308217 A GB201308217 A GB 201308217A GB 201308217 D0 GB201308217 D0 GB 201308217D0
Authority
GB
United Kingdom
Prior art keywords
therapy
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1308217.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd filed Critical UCL Business Ltd
Priority to GBGB1308217.7A priority Critical patent/GB201308217D0/en
Publication of GB201308217D0 publication Critical patent/GB201308217D0/en
Priority to PCT/GB2014/051391 priority patent/WO2014181101A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
GBGB1308217.7A 2013-05-08 2013-05-08 Compounds and their use in therapy Ceased GB201308217D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1308217.7A GB201308217D0 (en) 2013-05-08 2013-05-08 Compounds and their use in therapy
PCT/GB2014/051391 WO2014181101A1 (en) 2013-05-08 2014-05-07 2-acyl-4-oxy-1,2-dihydropyrrol-5-one compounds for improving memory and cognitive function

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1308217.7A GB201308217D0 (en) 2013-05-08 2013-05-08 Compounds and their use in therapy

Publications (1)

Publication Number Publication Date
GB201308217D0 true GB201308217D0 (en) 2013-06-12

Family

ID=48627418

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1308217.7A Ceased GB201308217D0 (en) 2013-05-08 2013-05-08 Compounds and their use in therapy

Country Status (2)

Country Link
GB (1) GB201308217D0 (en)
WO (1) WO2014181101A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3244725A (en) 1964-09-21 1966-04-05 Taub William 4, 5-diacyl-3-hydroxy-3-pyrrolin-2-ones
DE2636722A1 (en) 1976-08-14 1978-02-16 Goedecke Ag 3-HYDROXY-PYRROLINONE-2 DERIVATIVES
US4443616A (en) 1979-02-15 1984-04-17 The Purdue Frederick Company Production of 3-pyrrolin-2-ones
AU2001293869A1 (en) 2000-10-11 2002-04-22 Morphochem Ag Butenolide and pentenolide derivatives as kinase inhibitors
BR0211750A (en) 2001-08-10 2004-10-13 Shionogi & Co Antiviral agent
EP1348696B1 (en) 2002-03-26 2012-02-01 Institute Of Materia Medica, Chinese Academy Of Medical Sciences Use of optically active clausenamides for the preparation of pharmaceutical compositions, pharmaceutical compositions containing the same
EP1893574A2 (en) 2005-06-07 2008-03-05 Novartis AG Peptide deformylase (pdf) inhibitors 4
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
WO2010035727A1 (en) 2008-09-25 2010-04-01 塩野義製薬株式会社 Novel pyrrolinone derivative and medicinal composition containing same
SG183229A1 (en) 2010-03-10 2012-09-27 Probiodrug Ag Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)

Also Published As

Publication number Publication date
WO2014181101A1 (en) 2014-11-13

Similar Documents

Publication Publication Date Title
IL246239A0 (en) Bicyclic heterocycle compounds and their uses in therapy
GB201320729D0 (en) Therapeutic compounds and their use
HK1254296A1 (en) Therapeutic compounds and uses thereof
GB201319621D0 (en) Antimicrobial agents and their use in therapy
PL3065759T3 (en) Immunosuppressive agents and their use in therapy
HK1217092A1 (en) Therapeutic compounds and uses thereof
IL239904A0 (en) Inhibitory oligonucleotides and their use in therapy
ZA201607581B (en) Dosage forms and therapeutic uses l-4lchlorokynurenine
GB2515865B (en) Use of galactooligosaccharides in therapy
GB201311361D0 (en) Compounds and their therapeutic use
GB201308736D0 (en) Compounds and their therapeutic use
EP2946016A4 (en) Adenoviruses and their use
GB201308753D0 (en) Compounds and their use in therapy
HK1209033A1 (en) Use of odiparcil in the treatment of mucopolysaccharidosis
GB201308217D0 (en) Compounds and their use in therapy
GB201317804D0 (en) Therapeutic compounds and their use
GB201316173D0 (en) Compounds and their therapeutic use
GB201307677D0 (en) Compounds and their therapeutic use
GB201312128D0 (en) Drug combination and its use in therapy
GB201312129D0 (en) Drug combination and its use in therapy
GB201312131D0 (en) Drug combination and its use in therapy
GB201322755D0 (en) Bicyclic heterocycle compounds and their uses in therapy
EP3071207A4 (en) Libido-enhancing therapeutic and use
GB201320958D0 (en) Improvements in and relating to medical devices

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)